NEW CRYSTAL FORM OF RESMETIROM

NEW CRYSTAL FORM OF RESMETIROM
Product Description

Better chemical and mechanical stability than form I in

 Rezdiffra

Bioequivalence consistency with Rezdiffra

√Lower hygroscopicity than form I in Rezdiffra, et al.

Jiangsu Bioscene Pharmaceutical Co.,Ltd

  • Country/Region:
    China
  • On CPHI since:
    2024
  • Certificates:
    1
  • Employees:
    50 - 99
Company types
Contract Research Organisation (CRO)
Primary activities
Chemical Development
Specifications
  • CAS Registry Number
    920509-32-6
  • Selling Points
    Product Features

Jiangsu Bioscene Pharmaceutical Co.,Ltd

  • Country/Region:
    China
  • On CPHI since:
    2024
  • Certificates:
    1
  • Employees:
    50 - 99
Company types
Contract Research Organisation (CRO)
Primary activities
Chemical Development

More Products from Jiangsu Bioscene Pharmaceutical Co.,Ltd (2)

Jiangsu Bioscene Pharmaceutical Co.,Ltd resources (1)

  • Brochure Product Schedule

    We're focused on R&D and production of API and pharm-intermediates. The products which protected by valid patents are for labs R&D purposes only and are not offered for sales in countries where the sales of such products constitutes a patent infringement。